Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Sato

Showing results (501-510 of 514) with videos related to

Pageof 52
Sort By:
Medicines (Basel, Switzerland)|August 6, 2021
Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic CirrhosisAkihiko Shibamoto, Tadashi Namisaki, Junya Suzuki, et al.
Journal of Cancer|February 19, 2024
Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002)Senri Yamamoto, Masami Tsuchiya, Hirotoshi Iihara, et al.
Internal Medicine (Tokyo, Japan)|February 22, 2021
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study GroupMasahiko Chiwata, Hidehiro Itonaga, Shinya Sato, et al.
Internal Medicine (Tokyo, Japan)|July 9, 2025
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine MonotherapyTakafumi Furumoto, Koji Ando, Eo Toriyama, et al.
Nature Medicine|November 5, 2025
A multimodal whole-slide foundation model for pathologyTong Ding, Sophia J Wagner, Andrew H Song, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Clinical Significance of Serum Zinc Levels on the Development of Sarcopenia in Cirrhotic PatientsKoji Murata, Tadashi Namisaki, Yuki Fujimoto, et al.
Leukemia Research|November 23, 2013
Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study GroupHidehiro Itonaga, Hideki Tsushima, Daisuke Imanishi, et al.
Blood Advances|March 29, 2023
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasmsYasuhito Nannya, Magnus Tobiasson, Shinya Sato, et al.
The Journal of Clinical Investigation|November 15, 2023
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persistersMengjiao Li, Tatsunori Nishimura, Yasuto Takeuchi, et al.
Blood|October 25, 2021
Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutationsTakahiko Yasuda, Masashi Sanada, Masahito Kawazu, et al.
Pageof 52

Showing results (501-510 of 514) with videos related to

Sort By:
Pageof 52
Medicines (Basel, Switzerland)|August 6, 2021
Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic CirrhosisAkihiko Shibamoto, Tadashi Namisaki, Junya Suzuki, et al.
Journal of Cancer|February 19, 2024
Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002)Senri Yamamoto, Masami Tsuchiya, Hirotoshi Iihara, et al.
Internal Medicine (Tokyo, Japan)|February 22, 2021
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study GroupMasahiko Chiwata, Hidehiro Itonaga, Shinya Sato, et al.
Internal Medicine (Tokyo, Japan)|July 9, 2025
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine MonotherapyTakafumi Furumoto, Koji Ando, Eo Toriyama, et al.
Nature Medicine|November 5, 2025
A multimodal whole-slide foundation model for pathologyTong Ding, Sophia J Wagner, Andrew H Song, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Clinical Significance of Serum Zinc Levels on the Development of Sarcopenia in Cirrhotic PatientsKoji Murata, Tadashi Namisaki, Yuki Fujimoto, et al.
Leukemia Research|November 23, 2013
Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study GroupHidehiro Itonaga, Hideki Tsushima, Daisuke Imanishi, et al.
Blood Advances|March 29, 2023
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasmsYasuhito Nannya, Magnus Tobiasson, Shinya Sato, et al.
The Journal of Clinical Investigation|November 15, 2023
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persistersMengjiao Li, Tatsunori Nishimura, Yasuto Takeuchi, et al.
Blood|October 25, 2021
Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutationsTakahiko Yasuda, Masashi Sanada, Masahito Kawazu, et al.
Pageof 52